Navigation Links
Antipsychotics Do Help Many With Schizophrenia, Study Finds
Date:5/3/2012

THURSDAY, May 3 (HealthDay News) -- A new study finds that antipsychotic drugs can help many people with schizophrenia, cutting patients' risk of relapse by 60 percent.

The study, involving data stretching back 50 years, also found that schizophrenia patients who take antipsychotics are much less likely to be hospitalized and may behave less aggressively and have a better quality of life than patients who don't take the drugs.

One expert said the finding mirrors what he and other professionals have experienced.

The data "is consistent with what we see in clinical practice -- that we are very well able to keep our patients functioning better and out of the hospital when they consistently take these medications," said Dr. Roberto Estrada, attending psychiatrist at Lenox Hill Hospital in New York City.

The findings are published in the May 3 online edition of The Lancet.

In the study, German researchers combed through findings from 65 clinical trials reported in 116 articles published between 1959 and 2011. The trials included nearly 6,500 patients with schizophrenia.

After one year, relapse rates were 27 percent among patients who took antipsychotic drugs and 64 percent among those who took an inactive placebo, the review found. Rates of hospital readmission were 10 percent for patients who took antipsychotics and 26 percent for those who took a placebo.

Evidence from five studies indicated that patients who took antipsychotic drugs behaved less aggressively, and findings from three studies suggested that they have a better quality of life.

Antipsychotic drugs are the main type of treatment for people with schizophrenia, but they can cause serious side effects. Indeed, the investigators found that patients who took antipsychotic drugs had more negative side effects than those who took a placebo, including movement disorders (16 percent versus 9 percent), sedation (13 percent versus 9 percent), and weight gain (10 percent versus 6 percent).

Antipsychotic medications can also be expensive, the authors noted. In 2010, about $18.5 billion was spent worldwide on antipsychotic drugs, according to a journal news release.

Estrada agreed that the drugs have their drawbacks. "The cost and adverse effects associated with antipsychotics remain major impediments to achieving more successful treatment of schizophrenia," he said. "Further work needs to be done to develop more effective treatments for schizophrenia that are better-tolerated and thus likely to improve patients' adherence to taking these medications."

Still, the take-home message from the new study is clear, the study authors said.

"Antipsychotic maintenance treatment substantially reduces relapse risk in all patients with schizophrenia for up to 2 years of follow-up," Stefan Leucht from the Technical University of Munich, and colleagues, said in a journal news release "The effect was robust in important subgroups such as patients who had only one episode, those in remission," he added.

Benefits seemed to occur regardless of whether patients took older or newer forms of antipsychotic drugs, Leucht added. However, for many patients "the drugs seemed to lose their effectiveness with time," he said.

Another expert said that, while the medications are not perfect, they have eased the suffering of many patients.

"This study confirms clinical observations going back to the early 1950s -- that is, antipsychotic drugs are effective in reducing the symptoms associated with schizophrenia. The decreased number of patients in long-term mental health facilities, such as state mental hospitals, is a testimonial to this," said Dr. Norman Sussman, a psychiatrist at NYU Langone Medical Center and professor at the NYU School of Medicine in New York City.

"Hopefully, even better treatments will emerge in the near future that have fewer adverse effects and more robust therapeutic impact on cognition and social functioning," Sussman said.

More information

The U.S. National Institute of Mental Health has more about schizophrenia.

-- Robert Preidt

SOURCES: Roberto Estrada, M.D., attending psychiatrist, Lenox Hill Hospital, New York City; Norman Sussman, M.D., psychiatrist, NYU Langone Medical Center and professor of psychiatry, NYU School of Medicine, New York City; The Lancet, news release, May 2, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Atypical Antipsychotics Linked to Blood Clot Risk in Study
2. Parkinsons Patients Still Prescribed Antipsychotics Despite Warning
3. Patients Taking Antipsychotics Urged to Get Routine Physicals
4. Antipsychotics Best for Controlling Mania: Study
5. Mixed Results Seen With Off-Label Use of Antipsychotics
6. Genetic variation increases risk of metabolic side effects in children on some antipsychotics
7. Certain Antipsychotics Up Risk of Death for Patients With Dementia: Study
8. Large study finds genetic overlap between schizophrenia, bipolar disorder
9. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
10. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
11. TV drama can be more persuasive than news program, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antipsychotics Do Help Many With Schizophrenia, Study Finds
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended ... all facets of clinical trial planning and management. Pharmica discussed the importance of ... In addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
(Date:2/17/2017)... ... 17, 2017 , ... Like most hospitals across the nation, Onslow Memorial Hospital ... the Hospital Readmission Reduction Program (HRRP), the return of a patient to the hospital ... the nation. While many providers are struggling to leverage limited resources and technology, Onslow ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, ... expected to grow at a CAGR of 9.4% from 2017-2022 and ... at a CAGR of 9.5% from 2017 to 2027. The market ... ... benefit you Read on to discover how you can exploit ...
(Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
(Date:2/17/2017)... and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing ... ... the US, Canada , Japan , ... of World. Annual estimates and forecasts are provided for the period 2015 ... Market data and analytics are derived from primary and secondary research. ...
Breaking Medicine Technology: